Evidence map›Paper›PMID 40341552›Full record

ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2025

Clinical and pathological spectrum of disease severity among patients with acute liver failure (ALF) undergoing deceased donor liver transplantation.

Shannan R Tujios, Jody A Rule, Norman Sussman, Jorge L Rakela, Daniel Ganger, Nathan Bass, Adrian Reuben, R Todd Stravitz, David Kleiner, Hanlin Wang and 9 more

Abstract read
In one paragraph

Article in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shannan R TujiosDepartment of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Jody A RuleDepartment of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Norman SussmanBaylor College of Medicine, Houston, Texas, USA.
Jorge L RakelaDepartment of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, USA.
Daniel GangerDepartment of Medicine, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Nathan BassDepartment of Medicine, UC San Francisco, San Francisco, California, USA.
Adrian ReubenMedical University of South Carolina, Charleston, South Carolina, USA.
R Todd StravitzSection of Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA.
David KleinerPathology Section, National Cancer Institute, Bethesda, Maryland, USA.
Hanlin WangDepartment of Pathology, UCLA School of Medicine, Los Angeles, California, USA.
Eun-Young K ChoiDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Lan PengDepartment of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Matthew YehDepartment of Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Bryce HatfieldDepartment of Pathology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Guang-Yu YangDepartment of Pathology, Northwestern University School of Medicine, Chicago, Illinois, USA.
Ryan GillDepartment of Pathology, UC San Francisco, San Francisco, California, USA.
Robert J FontanaDepartment of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
William M LeeDepartment of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Acute Liver Failure Study Group

Funding

A Multi-Center Study of Acute Liver Failure in AdultsU01DK058369 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI DURKALSKI, VALERIE L, FONTANA, ROBERT J · 2005 to 2019
$27.4M
A MULTI-CENTER THERAPY TRIAL FOR ACUTE LIVER FAILURER01DK058369 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI LEE, WILLIAM M · 2000 to 2004
$4.2M
NIDDK NIH HHS R01 DK058369NIDDK NIH HHS U01 DK058369
6 · The paper itself

Abstract

Listing and transplanting patients with acute liver failure (ALF) is challenging, requiring rapid assessment of the likelihood of recovery. The availability of a large number of ALF liver explants, along with their clinical data, afforded an opportunity to retrospectively evaluate liver transplantation (LT) decision-making. We hypothesized that, with the benefit of hindsight, a small number of patients might have recovered without LT. Three hundred liver explants from ALF patients of varying etiologies who had undergone LT over 22 years in the Acute Liver Failure Study Group registry were reviewed for histopathological features and degree of necrosis by a committee of 8 hepatopathologists. A second committee of 8 experienced transplant hepatologists independently reviewed clinical data on these same 300 patients and retrospectively scored the likelihood that each patient required transplantation. Only 3 (1%) of those reviewed by the Clinical Committee were considered to "Definitely" not require liver grafting, while an additional 10 (3.3%) were deemed to "Possibly" not require transplantation (Not Likely Group, N=13). There was no difference in the degree of necrosis in explants in these groups, when compared to the remaining Likely Group, N=287 (95.6%), except in acetaminophen (APAP)-associated ALF, where the degree of necrosis was more uniformly graded as severe, correlating with the need for transplantation. Virtually every patient undergoing LT for ALF retrospectively appeared to need their transplant, based on expert clinical consensus review. Overall, there was poor correlation between clinical severity and apparent degree of necrosis seen in the 300 liver explants, except perhaps for APAP subjects.

Indexed as

LiverLiver Failure, AcuteLiver TransplantationAcetaminophenAdultAllograftsClinical Decision-MakingFemaleHumansMaleMiddle AgedNecrosisRegistriesRetrospective StudiesSeverity of Illness IndexTissue DonorsAcetaminophenacetaminophenliver explantsprognostic score

Identifiers

PMID40341552
PMCPMC12353392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.